我院中药注射剂使用情况统计与分析
|
摘要
目的:了解某医院中药注射剂的使用情况,为临床合理用药提供依据。方法:随机抽取2016年某月住院药房医嘱5 086条,并从中选取使用中药注射剂的医嘱,根据《中华人民共和国药典》二部、《处方管理办法》、《中药注射剂临床使用基本原则》、药品说明书对中药注射剂使用情况进行统计分析。结果:2016年某月某医院中药注射剂的使用率为38.7%,其中使用率较高的中药注射剂分别为丹红注射液、注射用血栓通、参麦注射液。科室使用情况中骨科使用率为32%,综合内科使用率为15%,神经内外科使用率为14%。联合用药情况二联用药占比68.3%,三联用药占比5.9%,四联及四联以上用药占比为3.1%。结论:某医院中药注射剂使用情况基本合理,但仍存在不合理的问题,需进一步加强中药注射剂的管理和培训,提高中药注射剂的合理用药,保证患者用药安全。
Objective:To study the use of Traditional Chinese Medicine Injections in Our Hospital,that provides reference for rational use in clinic.Methods:5086 medication orders of inpatients in a month of 2016 were extracted randomly in our hospital,and medication orders of Traditional Chinese Medicine Injections were selected,that was analysed according to the second part of Chinese Pharmacopoeia,Implementation of Prescription Administrative Policy,the clinical use of basic TCM injections principles and reference drug instruction.Results:The use rate of traditional Chinese medicine injections was 38.7%,the higher rates of Traditional Chinese Medicine Injections were Danhong Injection,Xue Shuan Tong injection and Shenmai injection.The use rate of traditional Chinese medicine injections in orthopedics department was 32%,the use rate of traditional Chinese medicine injections in the internal medicine department was 15%,the use rate of traditional Chinese medicine injections in Neurology Department was 14%.The rate of combination of two drugs was 68.3%,the rate of combination of three drugs was 5.9%,the rate of combination of four drugs was 3.1%.Conclusion:The use of Traditional Chinese medicine injections was reasonable in our hospital,but there were some problems of irrational use.The management and training were strengthened,the rational use of traditional Chinese medicine injections was improved,the medication safety of inpatient was assured.
Objective:To study the use of Traditional Chinese Medicine Injections in Our Hospital,that provides reference for rational use in clinic.Methods:5086 medication orders of inpatients in a month of 2016 were extracted randomly in our hospital,and medication orders of Traditional Chinese Medicine Injections were selected,that was analysed according to the second part of Chinese Pharmacopoeia,Implementation of Prescription Administrative Policy,the clinical use of basic TCM injections principles and reference drug instruction.Results:The use rate of traditional Chinese medicine injections was 38.7%,the higher rates of Traditional Chinese Medicine Injections were Danhong Injection,Xue Shuan Tong injection and Shenmai injection.The use rate of traditional Chinese medicine injections in orthopedics department was 32%,the use rate of traditional Chinese medicine injections in the internal medicine department was 15%,the use rate of traditional Chinese medicine injections in Neurology Department was 14%.The rate of combination of two drugs was 68.3%,the rate of combination of three drugs was 5.9%,the rate of combination of four drugs was 3.1%.Conclusion:The use of Traditional Chinese medicine injections was reasonable in our hospital,but there were some problems of irrational use.The management and training were strengthened,the rational use of traditional Chinese medicine injections was improved,the medication safety of inpatient was assured.
引文
[1]梅娜,李国辉.中药注射剂急诊使用情况分析[J].中国中医药信息杂志,2010,17(5):100-102.
[2]王涛.住院患者中药注射剂应用调查与分析[J].临床合理用药杂志,2013,6(14):152-153.
[3]陈琪,陈晓群,陆清溪,等.我院2013年中药注射剂应用分析[J].工企医刊,2014,27(6):1131.
[4]王小伶.丹红注射液治疗糖尿病周围神经病变86例[J].世界中医药,2012,7(4):308-309.
[5]何广宏,董然.血栓通注射剂在骨科的临床应用研究进展[J].中国药房,2014,25(36):3449-3451.
[6]杜婧,杨薇,易丹辉,等.基于HIS“真实世界”的丹红注射液治疗冠心病患者合并用药分析[J].中国中药杂志,2011,36(20):2821-2824.
[7]张子彬,郑宗锷.充血性心力衰竭[M].2版.北京:科学技术文献出版社,1997:207-208.
[8]杨炜,唐继红,王雄彪.环磷腺苷葡胺联合参麦治疗支气管哮喘疗效观察[J].河北医药,2010,32(15):1999-2001.
[9]张健,陈卫东.血栓通注射液预防骨科手术后下肢深静脉血栓形成的临床观察[J].黑龙江医学,2015,36(9):668-669.
[10]易受香,严洁,林亚平,等.针刺胃经穴对M受体阻断大鼠胃电及脑肠肽的影响[J].中国中西医结合消化杂志,2002(4):203-205.
[11]汪喆,彭昊,李章华,等.鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响[J].武汉大学学报(医学版),2007(02):196-199;206;126.
[12]赵庆玲,周路军.参麦注射液联合低分子肝素钠治疗急性脑梗死疗效分析[J].内科,2014,9(5):554-555.
[2]王涛.住院患者中药注射剂应用调查与分析[J].临床合理用药杂志,2013,6(14):152-153.
[3]陈琪,陈晓群,陆清溪,等.我院2013年中药注射剂应用分析[J].工企医刊,2014,27(6):1131.
[4]王小伶.丹红注射液治疗糖尿病周围神经病变86例[J].世界中医药,2012,7(4):308-309.
[5]何广宏,董然.血栓通注射剂在骨科的临床应用研究进展[J].中国药房,2014,25(36):3449-3451.
[6]杜婧,杨薇,易丹辉,等.基于HIS“真实世界”的丹红注射液治疗冠心病患者合并用药分析[J].中国中药杂志,2011,36(20):2821-2824.
[7]张子彬,郑宗锷.充血性心力衰竭[M].2版.北京:科学技术文献出版社,1997:207-208.
[8]杨炜,唐继红,王雄彪.环磷腺苷葡胺联合参麦治疗支气管哮喘疗效观察[J].河北医药,2010,32(15):1999-2001.
[9]张健,陈卫东.血栓通注射液预防骨科手术后下肢深静脉血栓形成的临床观察[J].黑龙江医学,2015,36(9):668-669.
[10]易受香,严洁,林亚平,等.针刺胃经穴对M受体阻断大鼠胃电及脑肠肽的影响[J].中国中西医结合消化杂志,2002(4):203-205.
[11]汪喆,彭昊,李章华,等.鹿瓜多肽注射液对骨折愈合的作用及对血管内皮生长因子表达的影响[J].武汉大学学报(医学版),2007(02):196-199;206;126.
[12]赵庆玲,周路军.参麦注射液联合低分子肝素钠治疗急性脑梗死疗效分析[J].内科,2014,9(5):554-555.